Clinical Trials Directory

Trials / Completed

CompletedNCT04180631

Quantitative US for Hepatic Steatosis

Diagnostic Value of Quantitative Ultrasound Imaging Parameters for Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the diagnostic performance of quantitative ultrasound imaging parameter for the assessment of hepatic steatosis in patients with non-alcoholic fatty liver disease using magnetic resonance imaging proton density fat fraction (MRI-PDFF) and MR spectroscopy as the reference standard.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTQuantitative ultrasound imaging parameter (QUS)Quantitative ultrasound imaging parameters (QUS) are analyzed to evaluate hepatic steatosis

Timeline

Start date
2019-03-05
Primary completion
2020-01-19
Completion
2020-01-19
First posted
2019-11-27
Last updated
2021-08-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04180631. Inclusion in this directory is not an endorsement.